Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Javier Rodriguez

Showing results (371-380 of 437) with videos related to

Pageof 44
Sort By:
Nature Communications|November 16, 2019
Prolyl hydroxylase substrate adenylosuccinate lyase is an oncogenic driver in triple negative breast cancerGiada Zurlo, Xijuan Liu, Mamoru Takada, et al.
Neurology. Genetics|December 16, 2022
Efficacy and Safety of Leriglitazone in Patients With Friedreich Ataxia: A Phase 2 Double-Blind, Randomized Controlled Trial (FRAMES)Massimo Pandolfo, Kathrin Reetz, Alejandra Darling, et al.
Neonatology|October 26, 2023
External Validation of a Multivariate Model for Targeted Surfactant ReplacementFrancesco Raimondi, Pasquale Dolce, Claudio Veropalumbo, et al.
Cancer Chemotherapy and Pharmacology|September 19, 2018
Outcomes after neoadjuvant treatment with gemcitabine and erlotinib followed by gemcitabine-erlotinib and radiotherapy for resectable pancreatic cancer (GEMCAD 10-03 trial)Joan Maurel, Santiago Sánchez-Cabús, Berta Laquente, et al.
Journal of Immunology (Baltimore, Md. : 1950)|November 4, 2011
Pilot clinical trial of type 1 dendritic cells loaded with autologous tumor lysates combined with GM-CSF, pegylated IFN, and cyclophosphamide for metastatic cancer patientsCarlos Alfaro, Jose L Perez-Gracia, Natalia Suarez, et al.
Biochemical and Biophysical Research Communications|May 1, 2016
Prolyl hydroxylase-1 regulates hepatocyte apoptosis in an NF-κB-dependent mannerSusan F Fitzpatrick, Zsolt Fábián, Bettina Schaible, et al.
Ebiomedicine|April 13, 2019
Unmasking a new prognostic marker and therapeutic target from the GDNF-RET/PIT1/p14ARF/p53 pathway in acromegalyMiguel Chenlo, Iria A Rodriguez-Gomez, Ramon Serramito, et al.
The Lancet. Oncology|May 7, 2021
Trastuzumab deruxtecan (DS-8201) in patients with HER2-expressing metastatic colorectal cancer (DESTINY-CRC01): a multicentre, open-label, phase 2 trialSalvatore Siena, Maria Di Bartolomeo, Kanwal Raghav, et al.
Neonatology|July 6, 2022
Lung Ultrasound Scores Progress Differently in Extreme and Very Preterm Infants after Birth: A Multicentre Prospective StudyAlmudena Alonso-Ojembarrena, Jon Montero-Gato, Rebeca Gregorio-Hernández, et al.
EMBO Molecular Medicine|June 14, 2017
Targeting endothelin receptor signalling overcomes heterogeneity driven therapy failureMichael P Smith, Emily J Rowling, Zsofia Miskolczi, et al.
Pageof 44

Showing results (371-380 of 437) with videos related to

Sort By:
Pageof 44
Nature Communications|November 16, 2019
Prolyl hydroxylase substrate adenylosuccinate lyase is an oncogenic driver in triple negative breast cancerGiada Zurlo, Xijuan Liu, Mamoru Takada, et al.
Neurology. Genetics|December 16, 2022
Efficacy and Safety of Leriglitazone in Patients With Friedreich Ataxia: A Phase 2 Double-Blind, Randomized Controlled Trial (FRAMES)Massimo Pandolfo, Kathrin Reetz, Alejandra Darling, et al.
Neonatology|October 26, 2023
External Validation of a Multivariate Model for Targeted Surfactant ReplacementFrancesco Raimondi, Pasquale Dolce, Claudio Veropalumbo, et al.
Cancer Chemotherapy and Pharmacology|September 19, 2018
Outcomes after neoadjuvant treatment with gemcitabine and erlotinib followed by gemcitabine-erlotinib and radiotherapy for resectable pancreatic cancer (GEMCAD 10-03 trial)Joan Maurel, Santiago Sánchez-Cabús, Berta Laquente, et al.
Journal of Immunology (Baltimore, Md. : 1950)|November 4, 2011
Pilot clinical trial of type 1 dendritic cells loaded with autologous tumor lysates combined with GM-CSF, pegylated IFN, and cyclophosphamide for metastatic cancer patientsCarlos Alfaro, Jose L Perez-Gracia, Natalia Suarez, et al.
Biochemical and Biophysical Research Communications|May 1, 2016
Prolyl hydroxylase-1 regulates hepatocyte apoptosis in an NF-κB-dependent mannerSusan F Fitzpatrick, Zsolt Fábián, Bettina Schaible, et al.
Ebiomedicine|April 13, 2019
Unmasking a new prognostic marker and therapeutic target from the GDNF-RET/PIT1/p14ARF/p53 pathway in acromegalyMiguel Chenlo, Iria A Rodriguez-Gomez, Ramon Serramito, et al.
The Lancet. Oncology|May 7, 2021
Trastuzumab deruxtecan (DS-8201) in patients with HER2-expressing metastatic colorectal cancer (DESTINY-CRC01): a multicentre, open-label, phase 2 trialSalvatore Siena, Maria Di Bartolomeo, Kanwal Raghav, et al.
Neonatology|July 6, 2022
Lung Ultrasound Scores Progress Differently in Extreme and Very Preterm Infants after Birth: A Multicentre Prospective StudyAlmudena Alonso-Ojembarrena, Jon Montero-Gato, Rebeca Gregorio-Hernández, et al.
EMBO Molecular Medicine|June 14, 2017
Targeting endothelin receptor signalling overcomes heterogeneity driven therapy failureMichael P Smith, Emily J Rowling, Zsofia Miskolczi, et al.
Pageof 44